Literature DB >> 18815861

Von Willebrand factor, red cell fragmentation, and disease activity in systemic lupus erythematosus.

Rodolfo V Curiel1, Rajkumari Bhagati, Lakshmi Basavaraju, Delona Norton, James Katz, Elizabeth Haile, Arthur Weinstein.   

Abstract

This study sought to determine whether the plasma levels of Von Willebrand factor (vWf) and the degree of red blood cell (RBC) fragmentation on peripheral smear correlate with disease activity in systemic lupus erythematosus (SLE). Forty consecutive patients who fulfilled the criteria for SLE were studied prospectively for 1 year. Patients were categorized according to the SLE Disease Activity Index (SLEDAI) as either active (>2) or inactive disease and followed up monthly (active) or quarterly (inactive). At each visit, patients were examined fully and had complete blood count, tests on antibodies to double-stranded DNA, C3, and C4 levels, and urinalysis. Citrated plasma was analyzed for vWf antigen by standard enzyme-linked immunosorbent assay. A Wright's stained blood smear was obtained and schistocytes were quantitated on blood smear. The number of schistocytes per 500 RBCs was determined and a schistocyte index (SI) was calculated. At baseline, vWf correlated with SLEDAI (r = 0.64, p < 0.01), SI correlated with SLEDAI (r = 0.62, p < 0.01), and vWf and SI correlated with each other (r = 0.41, p = 0.01). There was an inverse correlation between baseline C3 levels and vWf (r = 0.49, p = 0.0013) and C3 levels and SI (r = 0.40, p = 0.01). Over time, there was also a correlation of SLEDAI with vWf (r = 0.53, p = 0.002) and SI (r = 0.57;p = 0.002). The relation of vWf with SI approached but did not reach statistical significance (r = 0.37, p = 0.06). We found that the plasma levels of vWf and the degree of RBC fragmentation correlate with lupus disease activity over time. Therefore, inflammation in SLE may be associated with endothelial injury.

Entities:  

Year:  2008        PMID: 18815861      PMCID: PMC2553164          DOI: 10.1007/s11420-008-9080-9

Source DB:  PubMed          Journal:  HSS J        ISSN: 1556-3316


  33 in total

1.  Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells.

Authors:  E M Paleolog; D C Crossman; J H McVey; J D Pearson
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

2.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

3.  Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

Authors:  Sergio M A Toloza; América G Uribe; Gerald McGwin; Graciela S Alarcón; Barri J Fessler; Holly M Bastian; Luis M Vilá; Ruihua Wu; Yehuda Shoenfeld; Jeffrey M Roseman; John D Reveille
Journal:  Arthritis Rheum       Date:  2004-12

4.  Endothelium-dependent vasodilatation and essential hypertension.

Authors:  J A Panza
Journal:  N Engl J Med       Date:  1994-10-06       Impact factor: 91.245

5.  von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation.

Authors:  J A van Mourik; R Boertjes; I A Huisveld; K Fijnvandraat; D Pajkrt; P J van Genderen; R Fijnheer
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

6.  Summarizing disease features over time: II. Variability measures of SLEDAI-2K.

Authors:  Dominique Ibañez; Dafna Gladman; Murray Urowitz
Journal:  J Rheumatol       Date:  2006-12-15       Impact factor: 4.666

7.  Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy.

Authors:  Kausik K Ray; David A Morrow; C Michael Gibson; Sabina Murphy; Elliott M Antman; Eugene Braunwald
Journal:  Eur Heart J       Date:  2005-01-26       Impact factor: 29.983

Review 8.  Atherosclerosis and systemic lupus erythematosus.

Authors:  M Urowitz; D Gladman; I Bruce
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

9.  Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival.

Authors:  F Bridoux; F Vrtovsnik; C Noël; P Saunier; B Mougenot; V Lemaitre; M Dracon; G Lelièvre; P Vanhille
Journal:  Nephrol Dial Transplant       Date:  1998-02       Impact factor: 5.992

10.  Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension.

Authors:  A A Lopes; N Y Maeda
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

View more
  4 in total

1.  Loss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice.

Authors:  Nanette Mittereder; Ellen Kuta; Geetha Bhat; Karma Dacosta; Lily I Cheng; Ronald Herbst; Gianluca Carlesso
Journal:  J Immunol       Date:  2016-06-13       Impact factor: 5.422

Review 2.  Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.

Authors:  Naser Al-Husban; Oqba Al-Kuran
Journal:  J Med Case Rep       Date:  2018-06-01

3.  Evaluation of Impact of Interferon-Induced Helicase C Domain-Containing Protein 1 Gene in Egyptian Systemic Lupus Erythematosus Patients and its Relationship With Vascular Manifestations of the Disease.

Authors:  Sahar Nassef; Mervat Essam; Dina Abdelfattah; Doaa Elsehemy; Sahar Abouelezz
Journal:  Arch Rheumatol       Date:  2018-01-29       Impact factor: 1.472

4.  Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation.

Authors:  Johannes C Nossent; Warren D Raymond; Gro Østli Eilertsen
Journal:  Lupus Sci Med       Date:  2016-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.